05/ 15/ 2026
Biocom Named Among “2026 China CRO Outstanding Brand Top 20” at 92nd PHARMCHINA
Biocom has been named among the "2026 China CRO Outstanding Brand Top 20" at the 92nd PHARMCHINA. The award recognizes the company’s full‑chain pharmaceutical R&D capabilities, steady business performance, and industry leadership. Learn more about Biocom’s commitment to innovating quality medicines for public health.
04/ 24/ 2026
Focus on Japan | Biocom Debuts at CPHI Japan, Exploring New Heights in Pharmaceutical Innovation And Quality
Biocom debuted at CPHI Japan 2026, connecting with Asian pharma leaders and showcasing APIs and intermediates. The event strengthened East Asian partnerships and confirmed Biocom’s adherence to ICH and global quality standards.
04/ 17/ 2026
Biocom at CPHI Japan 2026 | API Supplier Booth IF-43 Tokyo
Biocom will be exhibiting at CPHI Japan 2026, taking place from April 21–23, 2026 in Tokyo, Japan. We welcome partners and industry professionals to visit us at Booth IF-43.
